The difference is price is because PUMA did not do shareholder dilute deals keeping their outstanding share totally ridiculously low favoring today's shareholders and PUMA's market cap is just about twice that of Mannkind's because the market is seeing greater value today in PUMA than Mannkind. A great partnership deal could change those dynamics over night in favor of Mannkind.
Kevinmik. question about your comment of dilution. regardless of outstanding shares, apples to apples, Market cap includes the shares in total. I'm not sure I understand how this comes in to play to make MNKD worth less than PUMA. I know 30m vs 388m but Market cap includes these factors.
true but PUMA trades over $200 per share and MNKD at ~9.60 7/23/2014 so all things being equal. MNKD has greater value and and greater market base. this does prove to me at least that MNKD has fare great potential to explode upwards with a BP partner. PUMAN has Pfizer MNKD will have ?